C50
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - written informed consent - UICC stage I-III - 18-100 years - fatigue - ECOG 0-2 - standard-oncological treatment took place at least 12 months before inclusion in this study
Exclusion criteria
Exclusion criteria: - Patients in whom it can be assumed that, for linguistic, intellectual or other reasons, they are not in a position to recognise the importance of the clinical trial and to demonstrate the necessary compliance - Pregnancy or nursing period -patients with alcohol, medicine and/or drug addiction - Simultaneous participation in clinical studies; the last participation in a clinical study must have been at least 3 months ago - Presence of a mental illness requiring acute psychiatric treatment - no written consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of cancer-related fatigue | — |
Secondary
| Measure | Time frame |
|---|---|
| Health-related quality of life, psychosocial distress, insomnia | — |
Countries
Germany
Contacts
Forschungsinstitut Havelhöhe (FIH) gGmbH am Gemeinschaftskrankenhaus Havelhöhe